Sudarshini Ramanathan
@darshi_r
A/Professor of Neuroimmunology @Sydney_uni @syd_health; clinician scientist, NHMRC Investigator Fellow; Head, Translational Neuroimmunology Group
Congratulations @FabienneBrilot on this excellent paper!
Delighted to share our paper. ➡️ COVID-19 VAX boosters improve the longevity and cross-variant breadth of immune responses in #MS ➡️ machine-learning models predict protection or need of an extra booster. neurology.org/doi/10.1212/NX… @anneke_vdw @darshi_r @StuartTurville @syd_health
MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally sciencedirect.com/science/articl…
@darshi_r @FabienneBrilot @Benjamin_Trewin @RussellCDale
Our new paper is finally out! A terrific joint effort to advance our understanding of T cell mediated neurodegeneration in AE ! “Neuronal pSTAT1 hallmarks synaptic pathology in autoimmune encephalitis against intracellular antigens” link.springer.com/article/10.100…
Congratulations @Benjamin_Trewin ! Awesome to have this done! Well done on all your hard work and achievements over the last four years 🎉🎓 Take some time to celebrate
The thesis has landed! 🚀📚🎓 After years of rewrites, stats, and soul-searching, it’s finally real! Huge thanks to @darshi_r and co-supervisors @RussellCDale, @FabienneBrilot & the MOG-dawggz! 🤘 #PhD #Neuroimmunology #MOGAD #AcademicTwitter @Sydney_Uni @DBworm @TheMOGProject
Congratulations @Mayo_AING @neuro_bo @Johnsoltys4 and team for their elegant study delineating breakdown in central and peripheral tolerance in CASPR2 antibody positive encephalitis!
#CASPR2-#antibody diseases are provide clues to mechanisms of autoantigen-specific tolerance Here - in @ScienceAdvances - we show how central and peripheral B cell tolerance licences pathogenic CASPR2 antibody generation. science.org/doi/10.1126/sc… More below 👇🏿
Very pleased to share our latest review on pathogenesis and biomarkers of prognosis of #MOGAD by first author Jane Andersen. sciencedirect.com/science/articl… Have a look at the figures! @TheSumairaFDN @TheMOGProject @BrainMind_Usyd @syd_health
Congratulations @Mayo_AING and team for this well deserved recognition 🎉
This is a massive honour for me and my team. Thank you @PNASNews. Jakob, Ruby and Mateusz were especially amazing in making this happen. And delivering a really cool #translational #neuroimmunology paper which has both basic and clinically applied impact.
onlinelibrary.wiley.com/doi/full/10.10… Here is the first PROM (patient reported outcome measure) for patients with #LGI1 antibody #encephalitis Hopefully a major inroad to measuring this disease more carefully 👍 @AE_Alliance @MayoClinicNeuro @MayoFL_NeuroRes @MayoClinic @NDCNOxford
My group has an open postdoctoral position researching single cell and high dimensional flow cytometry data analysis in #MOGAD @kids_research @Sydney_Uni @ISNI_neuro @NeuroimmOZ Apply here and join us: usyd.wd3.myworkdayjobs.com/USYD_EXTERNAL_…
Although anti-LGI1 encephalitis is traditionally viewed as a form of “limbic” encephalitis, this study characterizes it as a global “network disorder” that affects both limbic and extralimbic brain systems: hubs.la/Q0355v3V0 #NeuroTwitter #NeuroX
Excited to share out study led by @_YanaSaid and in collaboration with the Mayo clinic group (including @EoinFlanagan14 @chenmayo ) reporting our real-world clinical experience with paired fixed and live CBA testing for MOG-IgG and AQP4-IgG. onlinelibrary.wiley.com/doi/10.1002/ac…
Our new CASPR2 paper is out @ANA_journals 🤩 Headlines: Patients have neuropathic pain & fatigue as their main long term complaints which determine QoL. 😰 These are NOT immunotherapy responsive. 👩🏾⚕️💊 We also report other nuggets in this thread 🧵 ⬇️ onlinelibrary.wiley.com/doi/10.1002/an…